These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 33970778

  • 1. PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.
    Li M, Mu XD, Song JR, Zhai PT, Cheng Y, Le Y, Li ZB.
    Cell Cycle; 2021 May; 20(10):1010-1020. PubMed ID: 33970778
    [Abstract] [Full Text] [Related]

  • 2. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 3. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling.
    Xu Q, Xu HX, Li JP, Wang S, Fu Z, Jia J, Wang L, Zhu ZF, Lu R, Yao Z.
    Oncotarget; 2017 Mar 07; 8(10):16972-16987. PubMed ID: 28199981
    [Abstract] [Full Text] [Related]

  • 4. Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target.
    Ma XL, Sun YF, Wang BL, Shen MN, Zhou Y, Chen JW, Hu B, Gong ZJ, Zhang X, Cao Y, Pan BS, Zhou J, Fan J, Guo W, Yang XR.
    BMC Cancer; 2019 Aug 01; 19(1):760. PubMed ID: 31370822
    [Abstract] [Full Text] [Related]

  • 5. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM-/CD133- nonStem Cells into EpCAM+/CD133+ Liver Cancer Stem Cells in HCC Cell Line HuH7.
    Karagonlar ZF, Akbari S, Karabicici M, Sahin E, Avci ST, Ersoy N, Ates KE, Balli T, Karacicek B, Kaplan KN, Celiker C, Atabey N, Erdal E.
    Cells; 2020 May 12; 9(5):. PubMed ID: 32408542
    [Abstract] [Full Text] [Related]

  • 6. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.
    Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z.
    BMC Gastroenterol; 2011 Jun 14; 11():71. PubMed ID: 21669008
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Zinc finger protein X-linked promotes expansion of EpCAM+ cancer stem-like cells in hepatocellular carcinoma.
    Wang C, Fu SY, Wang MD, Yu WB, Cui QS, Wang HR, Huang H, Dong W, Zhang WW, Li PP, Lin C, Pan ZY, Yang Y, Wu MC, Zhou WP.
    Mol Oncol; 2017 May 14; 11(5):455-469. PubMed ID: 28156061
    [Abstract] [Full Text] [Related]

  • 9. COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling.
    Cai MN, Chen DM, Chen XR, Gu YR, Liao CH, Xiao LX, Wang JL, Lin BL, Huang YH, Lian YF.
    Cell Oncol (Dordr); 2024 Oct 14; 47(5):1897-1910. PubMed ID: 39080215
    [Abstract] [Full Text] [Related]

  • 10. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
    Yang C, Cai WC, Dong ZT, Guo JW, Zhao YJ, Sui CJ, Yang JM.
    Gene; 2019 Mar 01; 687():73-81. PubMed ID: 30391438
    [Abstract] [Full Text] [Related]

  • 11. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H, Li Y, Li X, Zhang W, Li S, Martin RCG.
    BMC Cancer; 2018 Aug 03; 18(1):783. PubMed ID: 30075764
    [Abstract] [Full Text] [Related]

  • 12. Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients.
    Xiang D, Cheng Z, Liu H, Wang X, Han T, Sun W, Li X, Yang W, Chen C, Xia M, Liu N, Yin S, Jin G, Lee T, Dong L, Hu H, Wang H, Ding J.
    Hepatology; 2017 May 03; 65(5):1566-1580. PubMed ID: 28059452
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway.
    Cheng Z, Lei Z, Yang P, Si A, Xiang D, Zhou J, Hüser N.
    Gene; 2019 Feb 05; 684():95-103. PubMed ID: 30359743
    [Abstract] [Full Text] [Related]

  • 14. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
    Liu F, Wu X, Jiang X, Qian Y, Gao J.
    J Exp Clin Cancer Res; 2018 Jun 25; 37(1):122. PubMed ID: 29940988
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW, Leung CON, Lau EY, Chung KPS, Mok EH, Lei MML, Leung RWH, Tong M, Keng VW, Ma C, Zhao Q, Ng IOL, Ma S, Lee TK.
    Cancer Res; 2021 Jun 15; 81(12):3229-3240. PubMed ID: 33903122
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
    Cheung PF, Cheung TT, Yip CW, Ng LW, Fung SW, Lo CM, Fan ST, Cheung ST.
    Oncotarget; 2016 Apr 19; 7(16):21644-57. PubMed ID: 26942873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.